ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,016,000 | +35.1% | 775,246 | +81.6% | 0.00% | -50.0% |
| Q4 2021 | $752,000 | +28.8% | 427,008 | +58.8% | 0.00% | +100.0% |
| Q3 2021 | $584,000 | -23.7% | 268,953 | +23.1% | 0.00% | -50.0% |
| Q2 2021 | $765,000 | -59.9% | 218,405 | +12.9% | 0.00% | -71.4% |
| Q1 2021 | $1,907,000 | +66.7% | 193,470 | +83.4% | 0.01% | +75.0% |
| Q4 2020 | $1,144,000 | +64.8% | 105,519 | +56.7% | 0.00% | +33.3% |
| Q3 2020 | $694,000 | -27.9% | 67,329 | +46.1% | 0.00% | -50.0% |
| Q2 2020 | $962,000 | +353.8% | 46,089 | +112.5% | 0.01% | +200.0% |
| Q1 2020 | $212,000 | -4.5% | 21,691 | +12.2% | 0.00% | +100.0% |
| Q4 2019 | $222,000 | +138.7% | 19,325 | +13.5% | 0.00% | 0.0% |
| Q3 2019 | $93,000 | – | 17,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |